Arcus biosciences reports qtrly loss per share of $0.93

Arcus biosciences announces second quarter 2020 financial results and corporate updates.qtrly loss per share $0.93.q2 earnings per share view $-0.61 -- refinitiv ibes data.
RCUS Ratings Summary
RCUS Quant Ranking